JOSE ALCANTAR: Open Payments
NPI 1871886382 · NATIONAL CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,012 in 92 payments from 17 companies in 2025. Trend: 2023 $5,434 · 2024 $3,158 · 2025 $2,012
Food & beverage: $1,940Education: $72
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 13 | $460 |
| Amgen Inc. | 17 | $311 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $199 |
| ABIOMED | 5 | $194 |
| BIOTRONIK INC. | 15 | $152 |
| PFIZER INC. | 13 | $141 |
| Novo Nordisk Inc | 1 | $121 |
| Novartis Pharmaceuticals Corporation | 6 | $106 |
| Lilly USA, LLC | 3 | $79 |
| Actelion Pharmaceuticals US, Inc. | 1 | $72 |
Products named: Repatha, Kerendia, WATCHMAN, ELIQUIS, WATCHMAN FLX, Wegovy, LEQVIO, FARAPULSE.
Industry payments across CA — which companies pay providers there.
